Human Hematopoietic Stem Cell Isolation From Cord Blood

AB Adeline N. Boettcher
YL Yunsheng Li
AA Amanda P. Ahrens
MK Matti Kiupel
KB Kristen A. Byrne
CL Crystal L. Loving
AC A. Giselle Cino-Ozuna
JW Jayne E. Wiarda
MA Malavika Adur
BS Blythe Schultz
JS Jack J. Swanson
ES Elizabeth M. Snella
CH Chak-Sum (Sam) Ho
SC Sara E. Charley
ZK Zoe E. Kiefer
JC Joan E. Cunnick
EP Ellie J. Putz
GD Giuseppe Dell'Anna
JJ Jackie Jens
SS Swanand Sathe
FG Frederick Goldman
EW Erik R. Westin
JD Jack C. M. Dekkers
JR Jason W. Ross
CT Christopher K. Tuggle
request Request a Protocol
ask Ask a question
Favorite

Human cord blood was collected at the Mary Greeley Medical Center in Ames, Iowa, into 50 mL conical tubes containing 8 mL of anticoagulant citrate dextrose solution (38 mM citric acid, 85.25 mM sodium citrate, 136 mM dextrose). Mononuclear cells (MNCs) were isolated from cord blood by diluting blood 1:2 in HBSS and then layering over Ficoll-Paque (GE Healthcare). Buffy coats were collected and washed in HBSS. Prior to stem cell isolation, MNCs were resuspended in an isolation HBSS (iHBSS) consisting of 0.5% FBS and 2 mM EDTA in HBSS.

To isolate human CD34+ cells, we used a CD34 MicroBead kit from Miltenyi Biotech. Briefly, MNCs were incubated in iHBSS with CD34 microbeads and FcR blocking reagent for 30 min at 4°C on a rocker. After the incubation period, cells were washed in iHBSS and then passed through a LS column in a Miltenyi magnet (Miltenyi Biotech) to capture human CD34+ cells. The column was then removed from the magnet and cells were flushed, washed once more in HBSS, and then frozen in 10% DMSO and 90% FBS at −80°C until use.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A